New treatment for pancreatic cancer shows improved survival rates

An experimental drug for pancreatic cancer has demonstrated improved survival rates after extensive research. The drug, which is administered once daily, has been shown to slow the progression of pancreatic cancer, a disease known for its high mortality rate. Dr. Rachna Shroff, associate director of clinical investigations at the University of Arizona Comprehensive Cancer Center, discussed the findings in an interview.